Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    AMEX: UPAR · Real-Time Price · USD
    13.79
    -0.18 (-1.31%)
    At close: Jun 13, 2025, 3:59 PM
    13.39
    -2.90%
    After-hours: Jun 13, 2025, 05:05 PM EDT
    -1.31%
    Bid 10.42
    Market Cap 58.67M
    Revenue (ttm) -
    Net Income (ttm) -
    EPS (ttm) 0.84094113
    PE Ratio (ttm) 16.4
    Forward PE n/a
    Analyst n/a
    Ask 17.26
    Volume 27,809
    Avg. Volume (20D) 11,485
    Open 13.95
    Previous Close 13.97
    Day's Range 13.77 - 13.95
    52-Week Range 12.02 - 15.06
    Beta undefined

    About UPAR

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol UPAR
    Website n/a
    Full Company Profile
    news image

    2 years ago · businesswire.com

    NorthStar Medical Radioisotopes Provides Updates on Corporate Progress and Upcoming Milestones

    BELOIT, Wis.--(BUSINESS WIRE)--NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic and medical im...

    news image

    2 years ago · businesswire.com

    Conjugated Monoclonal Antibodies Global Market Research Report 2022 - ResearchAndMarkets.com

    DUBLIN--(BUSINESS WIRE)--The "Conjugated Monoclonal Antibodies Global Market Report 2022: By Drugs, By Technology, By Application" report has been added to ResearchAndMarkets.com's offering. The globa...

    news image

    3 years ago · businesswire.com

    Conjugated Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth and Change to 2030 - ResearchAndMarkets.com

    DUBLIN--(BUSINESS WIRE)--The "Conjugated Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The global con...

    news image

    3 years ago · etftrends.com

    Toroso Launches Leveraged ETF for Investors Seeking More Upside

    On Tuesday, Toroso Asset Management launched the UPAR Ultra Risk Parity ETF (UPAR), expanding its line-up of risk parity ETFs with a new product aimed at investors looking for more upside. The new act...

    news image

    7 years ago · businesswire.com

    Real-Time Monitoring of Melanoma Cell Invasion Helps Scientists Elucidate Key Regulators of Metastasis

    SAN DIEGO--(BUSINESS WIRE)--A team of Italian scientists reported this week that blocking the interaction between urokinase receptor (uPAR) and formyl peptide receptor type 1 (FPR1) suppresses the abi...

    news image

    7 years ago · businesswire.com

    Onxeo Grants Exclusive Worldwide License of Validive® Developed for the Treatment of Oral Severe Mucositis to Monopar Therapeutics

    PARIS--(BUSINESS WIRE)--Regulatory News: Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or the “Company”), a clinical-stage biotechnology company specializing in the development of in...

    news image

    7 years ago · businesswire.com

    Onxeo concède à Monopar Therapeutics une licence mondiale exclusive de Validive®, développé dans le traitement de la mucite orale sévère

    PARIS--(BUSINESS WIRE)--Regulatory News: Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen : ONXEO), (« Onxeo » ou la « Société »), société de biotechnologie au stade clinique spécialisée dans le développ...

    Add to Watchlist